Head and Neck Carcinoma Clinical Trial
Official title:
IAEA-HypoX. A Randomized Multicenter Study of Accelerated Fractionated Radiotherapy With or Without the Hypoxic Radiosensitizer Nimorazole in the Treatment of Squamous Cell Carcinoma of the Head and Neck
The purpose of this study is to test the hypothesis that radiotherapy of head and neck carcinoma can be improved by hypoxic modification of radiotherapy using nimorazole as a hypoxic radiosensitizer in association with accelerated fractionation, in an unselected patient population in a global environment.
Squamous cell carcinoma in the head & neck region (HNSCC) accounts for approximately 7% of
all cancers worldwide & around 75% of all HNSCC cases are seen in the less developed
countries.
Significant improvement in loco-regional control & disease specific survival by radiation
therapy could be achieved by reducing the overall treatment time by "Accelerated
Fractionation" schedule.
Modification of hypoxia by Nimorazole demonstrated significant improved local effect of
radiation with neither serious nor lasting side effects. So, it is expected that the optimal
treatment option is reducing the overall treatment time with concomitant use of Nimorazole.
Such treatment principle is optimal for testing in developing countries.
The aim of the study:
- To determine the possible therapeutic gain of using nimorazole given as a hypoxic
radiosensitizer in conjunction with accelerated fractionated radiotherapy of invasive
squamous cell carcinoma of the larynx, pharynx and oral cavity, and
- To determine whether the addition of Nimorazole to primary curative radiotherapy is
feasible and tolerable on a worldwide scale.
- To evaluate the tolerance, compliance and toxicity of using nimorazole.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04110249 -
Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer
|
N/A | |
| Not yet recruiting |
NCT06289049 -
Heavy Strength Training in Head and Neck Cancer Survivors
|
Phase 2 | |
| Completed |
NCT01831089 -
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT03663985 -
FALCOn (Facteur AnthropoLogique Cancer Orl)
|
||
| Recruiting |
NCT05544136 -
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
|
Phase 2 | |
| Recruiting |
NCT05077072 -
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
|
Phase 2 | |
| Recruiting |
NCT04151082 -
High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
|
Phase 1/Phase 2 | |
| Completed |
NCT03964896 -
Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing Chemotherapy
|
N/A | |
| Recruiting |
NCT04147494 -
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
|
Early Phase 1 | |
| Completed |
NCT02474095 -
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
|
N/A | |
| Withdrawn |
NCT03261180 -
Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer
|
N/A | |
| Terminated |
NCT04618432 -
Collection of Clinical Data and Specimens for Research on Head and Neck and Communication Disorders
|
||
| Active, not recruiting |
NCT02615275 -
Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy
|
N/A | |
| Terminated |
NCT05012397 -
Milademetan in Advanced/Metastatic Solid Tumors
|
Phase 2 | |
| Recruiting |
NCT00991094 -
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
|
||
| Recruiting |
NCT04870762 -
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
|
Phase 2 | |
| Completed |
NCT02369835 -
Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
|
Phase 3 | |
| Completed |
NCT03902535 -
Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers
|
||
| Recruiting |
NCT05526924 -
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
|
Phase 1 | |
| Recruiting |
NCT03795610 -
Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
|
Phase 2 |